The Journal of Allergy and Clinical Immunology
Volume 123, Issue 1 , Pages 195-200 , January 2009

Antibody response to pneumococcal vaccination as a function of preimmunization titer

  • Nathaniel D. Hare, MD

      Affiliations

    • Division of Allergy-Immunology, Department of Internal Medicine, University of Iowa Hospitals and Clinics, Iowa City, Iowa
    • Iowa City VA Medical Center, Iowa City, Iowa
    • ,
  • Brian J. Smith, MS, PhD

      Affiliations

    • Department of Biostatistics, University of Iowa, Iowa City, Iowa
    • ,
  • Zuhair K. Ballas, MD

      Affiliations

    • Division of Allergy-Immunology, Department of Internal Medicine, University of Iowa Hospitals and Clinics, Iowa City, Iowa
    • Iowa City VA Medical Center, Iowa City, Iowa
    • Corresponding Author InformationReprint requests: Zuhair K. Ballas, MD, Division of Allergy-Immunology, Department of Internal Medicine, C42/E-13, GH, University of Iowa Hospitals and Clinics, 200 Hawkins Dr, Iowa City, IA 52242.

Received 8 May 2008 ,Revised 11 September 2008 ,Accepted 11 September 2008.

References 

  1. Bonilla FA, Bernstein IL, Khan DA, Ballas ZK, Chinen J, Frank MM, et al. Practice parameter for the diagnosis and management of primary immunodeficiency. Ann Allergy Asthma Immunol. 2005;94(suppl 1):S1–S63
  2. Ballow M. Primary immunodeficiency disorders: antibody deficiency. J Allergy Clin Immunol. 2002;109:581–591
  3. Kamchaisatian W, Wanwatsuntikul W, Sleasman JW, Tangsinmankong N. Validation of current joint American Academy of Allergy, Asthma & Immunology and American College of Allergy, Asthma and Immunology guidelines for antibody response to the 23-valent pneumococcal vaccine using a population of HIV-infected children. J Allergy Clin Immunol. 2006;118:1336–1341
  4. Siber GR, Ransil BJ, Schiffman G. Graphical method for evaluating antibody response to vaccines. Infect Immun. 1980;28:641–644
  5. Landesman SH, Schiffman G. Assessment of the antibody response to pneumococcal vaccine in high-risk populations. Rev Infect Dis. 1981;3(suppl):S184–S197
  6. Ammann AJ, Schiffman G, Abrams D, Volberding P, Ziegler J, Conant M. B-cell immunodeficiency in acquired immune deficiency syndrome. JAMA. 1984;251:1447–1449
  7. Rodriguez-Barradas MC, Musher DM, Lahart C, Lacke C, Groover J, Watson D, et al. Antibody to capsular polysaccharides of Streptococcus pneumoniae after vaccination of human immunodeficiency virus-infected subjects with 23-valent pneumococcal vaccine. J Infect Dis. 1992;165:553–556
  8. Janoff EN, O'Brien J, Thompson P, Ehret J, Meiklejohn G, Duvall G, et al. Streptococcus pneumoniae colonization, bacteremia, and immune response among persons with human immunodeficiency virus infection. J Infect Dis. 1993;167:49–56
  9. Sorensen RU, Leiva LE, Javier FC, Sacerdote DM, Bradford N, Butler B, et al. Influence of age on the response to Streptococcus pneumoniae vaccine in patients with recurrent infections and normal immunoglobulin concentrations. J Allergy Clin Immunol. 1998;102:215–221
  10. Pickering JW, Martins TB, Greer RW, Schroder MC, Astill ME, Litwin CM, et al. A multiplexed fluorescent microsphere immunoassay for antibodies to pneumococcal capsular polysaccharides. Am J Clin Pathol. 2002;117:589–596
  11. Liang K-Y, Zeger SL. Longitudinal data analysis using generalized linear models. Biometrics. 1986;73:13–22
  12. Go ES, Ballas ZK. Anti-pneumococcal antibody response in normal subjects: a meta-analysis. J Allergy Clin Immunol. 1996;98:205–215
  13. Artz AS, Ershler WB, Longo DL. Pneumococcal vaccination and revaccination of older adults. Clin Microbiol Rev. 2003;16:308–318
  14. Rubins JB, Puri AK, Loch J, Charboneau D, MacDonald R, Opstad N, et al. Magnitude, duration, quality, and function of pneumococcal vaccine responses in elderly adults. J Infect Dis. 1998;178:431–440
  15. Brandão AP, de Oliveira TC, de Cunto Brandileone MC, Gonçalves JE, Yara TI, Simonsen V. Persistence of antibody response to pneumococcal capsular polysaccharides in vaccinated long term-care residents in Brazil. Vaccine. 2004;23:762–768
  16. Sankilampi U, Isoaho R, Bloigu A, Kivelä SL, Leinonen M. Effect of age, sex and smoking habits on pneumococcal antibodies in an elderly population. Int J Epidemiol. 1997;26:420–427
  17. Gleeson M, Pyne DB, McDonald WA, Clancy RL, Cripps AW, Horn PL, et al. Pneumococcal antibody responses in elite swimmers. Clin Exp Immunol. 1996;105:238–244
  18. Ko J, Radigan L, Cunningham-Rundles C. Immune competence and switched memory B cells in common variable immunodeficiency. Clin Immunol. 2005;116:37–41
  19. Siber GR, Schur PH, Aisenberg AC, Weitzman SA, Schiffman G. Correlation between serum IgG-2 concentrations and the antibody response to bacterial polysaccharide antigens. N Engl J Med. 1980;303:178–182
  20. Edwards E, Razvi S, Cunningham-Rundles C. IgA deficiency: clinical correlates and responses to pneumococcal vaccine. Clin Immunol. 2004;111:93–97
  21. Ambrosino DM, Schiffman G, Gotschlich EC, Schur PH, Rosenberg GA, DeLange GG, et al. Correlation between G2m(n) immunoglobulin allotype and human antibody response and susceptibility to polysaccharide encapsulated bacteria. J Clin Invest. 1985;75:1935–1942

 Dr Smith is supported by National Cancer Institute grant P30 CA086862-09. Dr Ballas is supported by VA Merit and National Institutes of Health grant AA014418-06.

 Disclosure of potential conflict of interest: B. J. Smith has received research support from the National Institutes of Health. Z. K. Ballas has consulting arrangements with Novartis DSMB (National Institute of Allergy and Infectious Diseases) and has received research support from Talecris Biotherapeutics, VA Merit Review, and the National Institutes of Health. N. D. Hare has declared that he has no conflict of interest.

PII: S0091-6749(08)01684-9

doi: 10.1016/j.jaci.2008.09.021

The Journal of Allergy and Clinical Immunology
Volume 123, Issue 1 , Pages 195-200 , January 2009

Article Tools

* Image Usage & Resolution